Inventor · disambiguated record
Louis Picker
Also filed as: PICKER LOUIS · PICKER LOUIS J
27 granted patents·12 pending applications·230 citations·filing 1991–2023
96Inventor score
Files withUNIV OREGON HEALTH & SCIENCE26BECTON DICKINSON CO3VIR BIOTECHNOLOGY INC3AERAS1INT AIDS VACCINE INITIATIVE INC1
Top patents by PatentIndex Score
39 records- 0196US10101329B2CMV glycoproteins and recombinant vectorsUNIV OREGON HEALTH & SCIENCE·Filed 2016·Granted Oct 16, 2018·9 cites·46 claims
- 0293US9783823B2Cytomegalovirus vectors enabling control of T cell targetingUNIV OREGON HEALTH & SCIENCE·Filed 2014·Granted Oct 10, 2017·14 cites·28 claims
- 0393US9249427B2Recombinant HCMV and RHCMV vectors and uses thereofUNIV OREGON HEALTH & SCIENCE·Filed 2012·Granted Feb 2, 2016·24 cites·24 claims
- 0492US9982241B2Recombinant HCMV and RHCMV vectors and uses thereofUNIV OREGON HEALTH & SCIENCE·Filed 2015·Granted May 29, 2018·13 cites·54 claims
- 0591US10688164B2CMV vectors comprising microRNA recognition elementsUNIV OREGON HEALTH & SCIENCE·Filed 2016·Granted Jun 23, 2020·8 cites·23 claims
- 0691US10532099B2Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E moleculesUNIV OREGON HEALTH & SCIENCE·Filed 2017·Granted Jan 14, 2020·8 cites·67 claims
- 0790US10316334B2Cytomegalovirus vectors enabling control of T cell targetingUNIV OREGON HEALTH & SCIENCE·Filed 2017·Granted Jun 11, 2019·4 cites·23 claims
- 0890US9862972B2CMV glycoproteins and recombinant vectorsUNIV OREGON HEALTH & SCIENCE·Filed 2013·Granted Jan 9, 2018·10 cites·55 claims
- 0990US9541553B2CMV glycoproteins and recombinant vectorsUNIV OREGON HEALTH & SCIENCE·Filed 2014·Granted Jan 10, 2017·10 cites·36 claims
- 1089US10894078B2HIV vaccines comprising one or more population episensus antigensVIR BIOTECHNOLOGY INC·Filed 2015·Granted Jan 19, 2021·4 cites·26 claims
- 1187US10760097B2CMV glycoproteins and recombinant vectorsUNIV OREGON HEALTH & SCIENCE·Filed 2017·Granted Sep 1, 2020·4 cites·18 claims
- 1285US10428118B2Human cytomegalovirus comprising exogenous antigensUNIV OREGON HEALTH & SCIENCE·Filed 2015·Granted Oct 1, 2019·5 cites·20 claims
- 1383US10995121B2Human cytomegalovirus comprising exogenous antigensUNIV OREGON HEALTH & SCIENCE·Filed 2019·Granted May 4, 2021·1 cites·30 claims
- 1481US11091779B2Methods and compositions useful in generating non canonical CD8+ T cell responsesUNIV OREGON HEALTH & SCIENCE·Filed 2020·Granted Aug 17, 2021·1 cites·20 claims
- 1576US12442018B2Recombinant cytomegalovirus vectors as vaccines for tuberculosisINT AIDS VACCINE INITITATIVE INC·Filed 2023·Granted Oct 14, 2025·0 cites·15 claims
- 1675US5622853AT lymphocyte precursorBECTON DICKINSON CO·Filed 1991·Granted Apr 22, 1997·36 cites·1 claims
- 1772US11834669B2Recombinant cytomegalovirus vectors as vaccines for tuberculosisINT AIDS VACCINE INITIATIVE INC·Filed 2021·Granted Dec 5, 2023·0 cites·23 claims
- 1872US11692012B2Human cytomegalovirus comprising exogenous antigensUNIV OREGON HEALTH & SCIENCE·Filed 2021·Granted Jul 4, 2023·0 cites·30 claims
- 1972US5583033AT lymphocyte precursorBECTON DICKINSON CO·Filed 1993·Granted Dec 10, 1996·30 cites·17 claims
- 2072US2022288191A1Siv and hiv vaccination using rhcmv- and hcmv-based vaccine vectorsUNIV OREGON HEALTH & SCIENCE·Filed 2021·Application pending·0 cites
- 2171US11628215B2HIV vaccines comprising one or more population episensus antigensVIR BIOTECHNOLOGY INC·Filed 2020·Granted Apr 18, 2023·0 cites·7 claims
- 2271US11554168B2HIV vaccines comprising one or more population episensus antigensVIR BIOTECHNOLOGY INC·Filed 2020·Granted Jan 17, 2023·0 cites·24 claims
- 2368US11266732B2Recombinant HCMV and RHCMV vectors and uses thereofUNIV OREGON HEALTH & SCIENCE·Filed 2018·Granted Mar 8, 2022·0 cites·10 claims
- 2468US2021338800A1Siv and hiv vaccination using rhcmv- and hcmv-based vaccine vectorsUNIV OREGON HEALTH & SCIENCE·Filed 2020·Application pending·0 cites
- 2565US2020140888A1Cytomegalovirus vectors enabling control of t cell targetingUNIV OREGON HEALTH & SCIENCE·Filed 2019·Application pending·0 cites
- 2662US11305015B2Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E moleculesUNIV OREGON HEALTH & SCIENCE·Filed 2019·Granted Apr 19, 2022·0 cites·19 claims
- 2762US2013142823A1Cmv glycoproteins and recombinant vectorsSCIENCE UNIVERSITY OREGON HEALTH AND·Filed 2012·Application pending·0 cites
- 2860US5316913ANeutrophil LECAM-1 as indicator of neutrophil activationUNIV STANFORD·Filed 1991·Granted May 31, 1994·20 cites·9 claims
- 2960US2021395771A9CMV Glycoproteins and Recombinant VectorsUNIV OREGON HEALTH & SCIENCE·Filed 2020·Application pending·0 cites
- 3059US11091775B2Recombinant cytomegalovirus vectors as vaccines for tuberculosisAERAS·Filed 2017·Granted Aug 17, 2021·0 cites·28 claims
- 3158US5612185AMethod for identifying tumor cells in cell cycle arrestUNIV TEXAS·Filed 1994·Granted Mar 18, 1997·21 cites·8 claims
- 3255US2008199493A1Siv and Hiv Vaccination Using Rhcmv- and Hcmv-Based Vaccine VectorsPICKER LOUIS J·Filed 2005·Application pending·0 cites
- 3354US2020368333A1Cmv vectors comprising microrna recognition elementsUNIV OREGON HEALTH & SCIENCE·Filed 2020·Application pending·0 cites
- 3452US2016354461A1Siv and hiv vaccination using rhcmv- and hcmv-based vaccine vectorsUNIV OREGON HEALTH & SCIENCE·Filed 2016·Application pending·0 cites
- 3551US2018298404A1Methods and compositions useful in generating non canonical cd8+ t cell responsesUNIV OREGON HEALTH & SCIENCE·Filed 2016·Application pending·0 cites
- 3650US2022307054A1Modulation of t cell responses by ul18 of human cytomegalovirusUNIV OREGON HEALTH & SCIENCE·Filed 2020·Application pending·0 cites
- 3750US2022257740A1Tumor-associated antigen-specific t cell responsesUNIV OREGON HEALTH & SCIENCE·Filed 2020·Application pending·0 cites
- 3849US2023272036A1Multi-specific t cell receptorsUNIV OREGON HEALTH & SCIENCE·Filed 2020·Application pending·0 cites
- 3934US7514232B2Method for detecting T cell response to specific antigens in whole bloodBECTON DICKINSON CO·Filed 1997·Granted Apr 7, 2009·8 cites·41 claims
Join the waitlist — get patent alerts
Get an alert when Louis Picker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →